reaction 4methylumbelliferylguanidinobenzo cultiv human skin fibroblast deriv patient cystic fibrosi proteas activ cultiv human skin fibroblast ha quantit use 4methylumbelliferylguanidinobenzo mugb activ site titrant trypsinlik proteas 7 reaction proteas mugb wa complet 1 hr inhibit benzamidin pnitrophenylpguanidinobenzo p hydroxymercuribenzo extent reaction wa proport protein concentr independ mugb concentr thi activ wa present particul fraction cell mean titr valu nanomol 4methylumbelliferon releas per mg protein proteas fibroblast eight control n 8 oblig heterozygot h 14 patient cystic fibrosi cf n 127 011 h 082 012 cf 066 010 differ titr valu ncf nh signific p less 0001 hcf p less 001 mean titr valu obtain cultiv control amniot fluid cell wa 129 017 data indic reduct mugb reactiv proteas skin fibroblast deriv patient cf compar either control oblig heterozygot data consist earlier suggest 11 15 decreas proteolyt level tissu fluid patient cf may gener phenomenon